The importance of pharmacokinetics, pharmacodynamic and repetitive use of levosimendan

This publication has 58 references indexed in Scilit:

• A structural and functional perspective into the mechanism of Ca2+-sensitizers that target the cardiac troponin complex
  Journal of Molecular and Cellular Cardiology, 2010
• Intravenous levosimendan-norepinephrine combination during off-pump coronary artery bypass grafting in a hemodialysis patient with severe myocardial dysfunction
  Journal of Cardiothoracic Surgery, 2010
• Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K_ATPchannel
  British Journal of Pharmacology, 2009
• Levosimendan in Aortic Valve Surgery: Cardiac Performance and Recovery
  Journal of Cardiothoracic and Vascular Anesthesia, 2008
• Pharmacokinetics of Intravenous Levosimendan and Its Metabolites in Subjects With Hepatic Impairment
  The Journal of Clinical Pharmacology, 2008
• Effect of Severe Renal Failure and Haemodialysis on the Pharmacokinetics of Levosimendan and Its Metabolites
  Clinical Pharmacokinetics, 2007
• Cardioprotection: A New Paradigm in the Management of Acute Heart Failure Syndromes
  The American Journal of Cardiology, 2005
• Effects of Levosimendan on Markers of Left Ventricular Diastolic Function and Neurohormonal Activation in Patients With Advanced Heart Failure
  The American Journal of Cardiology, 2005
• Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone
  The American Journal of Cardiology, 2005
• Pharmacodynamics and Pharmacokinetics of Oral Levosimendan and Its Metabolites in Patients With Severe Congestive Heart Failure: A Dosing Interval Study
  The Journal of Clinical Pharmacology, 2004